U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07086989) titled 'Cardiovascular Risk in Children With Chronic Conditions Study' on July 17. Brief Summary: ... Read More
U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07086976) titled 'A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Com... Read More
U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07086560) titled 'PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in ... Read More
U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07086040) titled 'Effects of RAS in SZ' on July 18. Brief Summary: The two main groups of medicated patients... Read More
U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07086872) titled 'Impact of Adding Integrated Neuromuscular Inhibition Technique to Mulligan Therapy in Sympt... Read More
U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07086794) titled 'Cocaine and Pentoxifylline (BED IN 47)' on July 18. Brief Summary: This will be a human la... Read More
U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07085494) titled 'A Double-Blind, Sham-Controlled Trial Investigating Individualized Alpha Neurofeedback Plus... Read More
U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07087080) titled 'Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benig... Read More
U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07085091) titled 'A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors' on Jun... Read More
U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07087223) titled 'Phase Ib/II Study of Vebreltinib With Furmonertinib in NSCLC Patients With c-Met Amplificat... Read More